HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gillespie, K. M. Articles by Bingley, P. J. Search for Related Content PubMed PubMed Citation Articles by Gillespie, K. M. Articles by Bingley, P. J. Social Bookmarking                What's this?

High Familial Risk and Genetic Susceptibility in Early Onset Childhood Diabetes

Department of Diabetes and Metabolism, Division of Medicine, University of Bristol, Bristol, U.K.

Early onset type 1 diabetes is associated with rapid ß-cell failure and high levels of HLA-mediated genetic susceptibility. We examined familial risk of disease in relation to age at onset in 1,299 families participating in the Bart’s Oxford population-based family study of type 1 diabetes. Risk of diabetes was estimated by survival analysis in 1,430 siblings and 2,419 parents and related to age at onset in the proband. Unaffected relatives at high risk were identified by measurement of islet autoantibodies, and HLA class II genotyping was performed in probands where DNA was available (573 children). The cumulative risk of diabetes by age 20 years was 11.7% in siblings of probands diagnosed before age 5 years, compared with 3.6% for ages 5–9 years and 2.3% for ages 10–14 years (P < 0.0001). In parents, the cumulative risk by age 40 years was 5.9% if the proband was diagnosed before age 5 years, compared with 3.7% for ages 5–9 years and 3.7% for ages 10–14 years (P = 0.04). Of 1,169 unaffected siblings tested at study entry, 7.3% had two or more autoantibody markers if the proband was diagnosed before age 5 years, compared with 2.2 and 2.4%, respectively, for ages 5–9 and 10–14 years (P = 0.002). The frequency of the highest risk genotype decreased with increasing age at onset. Of children diagnosed before age 5 years, 52% were heterozygous for HLA DRB1*03-DQA1*0501-DQB1*02/DRB1*04-DQA1*0301-DQB1*0302 compared with 32% and 33%, respectively, for children diagnosed at ages 5–9 and 10–14 years (P < 0.001). Diabetes with onset before age 5 years is therefore a marker of high familial risk.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. M. Gillespie Type 1 diabetes: pathogenesis and prevention. Can. Med. Assoc. J., July 18, 2006; 175(2): 165 - 170. [Abstract] [Full Text] [PDF]

				V. Harjutsalo, A. Reunanen, and J. Tuomilehto Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes, May 1, 2006; 55(5): 1517 - 1524. [Abstract] [Full Text] [PDF]

				P. Achenbach, E. Bonifacio, K. Koczwara, and A.-G. Ziegler Natural History of Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S25 - S31. [Abstract] [Full Text] [PDF]

				F. A. Al-Jenaidi, S. F. Wakim-Ghorayeb, A. Al-Abbasi, M. R. Arekat, N. Irani-Hakime, P. Najm, K. Al-Ola, A. A. Motala, and W. Y. Almawi Contribution of Selective HLA-DRB1/DQB1 Alleles and Haplotypes to the Genetic Susceptibility of Type 1 Diabetes among Lebanese and Bahraini Arabs J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5104 - 5109. [Abstract] [Full Text] [PDF]

				A. K. Steck, K. J. Barriga, L. M. Emery, R. V. Fiallo-Scharer, P. A. Gottlieb, and M. J. Rewers Secondary Attack Rate of Type 1 Diabetes in Colorado Families Diabetes Care, February 1, 2005; 28(2): 296 - 300. [Abstract] [Full Text] [PDF]

				V. Harjutsalo, T. Podar, and J. Tuomilehto Cumulative Incidence of Type 1 Diabetes in 10,168 Siblings of Finnish Young-Onset Type 1 Diabetic Patients Diabetes, February 1, 2005; 54(2): 563 - 569. [Abstract] [Full Text] [PDF]

				A. P. Lambert, K. M. Gillespie, G. Thomson, H. J. Cordell, J. A. Todd, E. A. M. Gale, and P. J. Bingley Absolute Risk of Childhood-Onset Type 1 Diabetes Defined by Human Leukocyte Antigen Class II Genotype: A Population-Based Study in the United Kingdom J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4037 - 4043. [Abstract] [Full Text] [PDF]

				E. M. Al-Harbi, A.-J. Abbassi, H. Tamim, F. al-Jenaidi, M. Kooheji, M. Kamal, S. al-Mahroos, F. al-Nasir, A. A. Motala, and W. Y. Almawi Specific HLA-DRB and -DQB Alleles and Haplotypes Confer Disease Susceptibility or Resistance in Bahraini Type 1 Diabetes Patients Clin. Vaccine Immunol., March 1, 2004; 11(2): 292 - 296. [Abstract] [Full Text] [PDF]

				G. J. Crowther, J. M. Milstein, S. A. Jubrias, M. J. Kushmerick, R. K. Gronka, and K. E. Conley Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E655 - E662. [Abstract] [Full Text] [PDF]

				E. A.M. Gale The Rise of Childhood Type 1 Diabetes in the 20th Century Diabetes, December 1, 2002; 51(12): 3353 - 3361. [Abstract] [Full Text] [PDF]